| UHC Commercial Medical & Drug | Percutaneous Patent Foramen Ovale (PFO) Closure - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Pharmacogenetic Panel Testing - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Plagiocephaly and Craniosynostosis Treatment - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Pneumatic Compression Devices - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Preimplantation Genetic Testing and Related Services - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Preventive Care Services - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Private Duty Nursing Services - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Prolotherapy and Platelet Rich Plasma Therapies - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Prostate Surgeries and Interventions - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Provider Administered Drugs - Site of Care - Commercial Medical Benefit Drug Policy | 2026-01-01 |